.svg){kind=small}
Where to Buy
Vlasic Labs is stocked at 179 licensed dispensaries across Michigan, Nevada, and 9 other states, 73 of them in Michigan, with the deepest coverage in Coldwater, Detroit, New Buffalo, Grand Rapids, and Center Line. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In September 2026, Vlasic Labs leaned on Tincture & Sublingual at 35.6% share despite a 29.3% month-over-month decline, while Topical held 27.2% share with a 30.7% MoM drop but a 61.5% year-over-year gain; together these two categories accounted for 62.9% of sales mix, concentrating exposure in segments with divergent momentum. Flower rose to 24.6% mix on a 101.8% MoM surge even as its year-over-year was down 13.4%, contrasting with Edible at 9.9% share with a 15.2% MoM and 33.5% YoY decline; this split implies the brand is pivoting toward inhalable demand recovery while maintaining a tincture/topical anchor that drives price but introduces volatility.
The mix shift—Flower’s triple-digit MoM rebound alongside Concentrates’ 52.4% MoM and 76.1% YoY expansion from a 0.5% base—suggests repositioning toward faster-cycling, trial-friendly formats, while the double-digit YoY price lift of 13.5% supports margin but raises elasticity risk in declining Edible (−33.5% YoY) and Pre-Roll (−54.5% YoY). With Flower ranked 50th in Nevada, the 24.6% share exposure to a lower-ranked category signals that volume gains are coming from tactical pricing or assortment breadth rather than rank-led pull; the implication is to consolidate tincture/topical price architecture while selectively scaling Flower where MoM velocity can convert into durable rank movement.
Competitive Landscape
Vlasic Labs sits at rank #50 in NV Flower for September 2026, improving 14 positions year over year from #64 and rising 25 spots versus June 2026’s #75, while still trailing its peak of #38 from April 2025; meanwhile, RYTHM held at #1 year over year with a 19.7% sales lift and STIIIZY stayed #2 with 24.2% YoY growth, indicating Vlasic Labs’ rank gains came amid leaders consolidating at the top. With Alternative Medicine Association / AMA moving up from #5 to #3 on 32.6% YoY sales growth and Neon Moon climbing from #9 to #4 on 82.7% YoY growth, the middle tier is compressing as fast risers outpace incremental movers; this pattern implies Vlasic Labs’ upward trajectory is real but hinges on sustaining share gains faster than competitors advancing 2–5 ranks in a single year.
Notable Products
Wilbur's Gelato (3.5g) posted the standout move in September 2026 with a 105.2% month-over-month gain and climbed to rank 3, while CBD Full Spectrum Relief Cream (3000mg CBD, 3oz) fell 21.0% yet held rank 1. CBD Broad Spectrum Tincture (3000mg CBD, 30ml, 1oz) dropped 27.4% at rank 2, and CBD Mini Relief Cream (500mg CBD, 0.5oz) slid 56.3% at rank 9 with $3,218 in sales. With three Flower SKUs in the top ten and the month’s only triple-digit mover coming from Flower, the mix implies a pivot toward inhalable demand at the expense of tinctures and topicals.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
